+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years - 75Years
All Genders
ID07434427

Evaluating Intravenous Buprenorphine Versus Oxycodone via Patient-Controlled Analgesia for Postoperative Pain After Video-Assisted Thoracoscopic Surgery

Led by Medical University of Silesia · Updated on 2026-09-25

200

Participants Needed

1

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether intravenous buprenorphine delivered through a patient-controlled analgesia PCA system provides effective and safer pain control after video-assisted thoracoscopic surgery VATS compared to intravenous oxycodone PCA in adults. This study aims to assess pain control during the first 48 hours after surgery, respiratory safety, opioid-related side effects, and longer-term pain outcomes. The trial is a prospective, randomized, double-blind clinical study involving adults undergoing elective VATS with standardized multimodal analgesia and anesthesia care. Participants will be randomly assigned to receive either buprenorphine PCA or oxycodone PCA for 48 hours after surgery, both alongside standard multimodal analgesia including a serratus anterior plane nerve block. Anesthesia involves general anesthesia with one-lung ventilation, and regional analgesia is provided via an ultrasound-guided serratus anterior plane block. The PCA dosing for buprenorphine is 0.02 mg per bolus with a 15-minute lockout, and for oxycodone 1 mg per bolus with the same lockout. Both groups receive standardized perioperative care and multimodal pain management. During the study, participants will have pain scores recorded at multiple time points over 48 hours at rest and during rehabilitation, and complete recovery questionnaires. Vital signs, sedation levels, respiratory events, and opioid use will be closely monitored. Satisfaction with analgesia will be assessed at hospital discharge, and follow-up visits at 1, 3, and 6 months will evaluate persistent postoperative pain. Safety, opioid consumption, quality of recovery, and adverse effects are among the key outcomes measured to compare these treatments.

CONDITIONS

Brief Title

Comparison of the Efficacy and Safety of Intravenous Buprenorphine Administered Via PCA System Versus Oxycodone in the Management of Postoperative Pain After Video-Assisted Thoracoscopic Surgery

Research Team

J

Justyna K Danel, Medical Doctor

P

Piotr Palaczyński, Doctor of Medicine

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here